OrganOx: The Oxford University Spin-Out Revolutionising Organ Donation

In this Curated podcast, we meet with the Co-Founders and CEO of OrganOx, an Oxford University spin-out that is quickly penetrating the world of medtech. Its success has led it to be at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation. Amazing as it may seem, methods of preserving organs have changed little in the last 30 years, however OrganOx has spent over a decade developing a radically different approach, such that observers have referred to it as a “Lifeline for Livers”, and a “Dream Machine”, with further potential applications. Peter Friend, Professor of Transplantation at Oxford University and Constantin Coussios, Professor of Biomedical Engineering at Oxford University, explain their work in combining a reappraisal of the medical challenge with the engineering approach undertaken to find a solution for a very real unmet medical need. They are joined by Craig Marshall, CEO of OrganOx (previously MD of the Siemens's magnet technology business), who explains why FDA approval launches the company onto a new plane, as well as other potentially compelling opportunities for the company. He discusses the journey from invention to monetisation, the revenue inflection point ahead, the market opportunity, board composition, and the excitement they share about the future. Subscribe to stay up to date with our range of fascinating interviews, featuring some of the biggest names in global finance and business! STAY UP TO DATE ✅ OrganOx: https://www.organox.com/ ✅ Newsletter: https://www.moneymazepodcast.com/contact ✅ LinkedIn:   / the-money-maze-podcast   ✅ X: https://x.com/themoneymazepod ✅ Instagram:   / moneymazepodcast   LISTEN: 🎧 Spotify: https://open.spotify.com/episode/21wl... 🎧 Apple Podcasts: https://podcasts.apple.com/gb/podcast... TOPICS: 0:00 - Introduction 1:45 - OrganOx's Origins 9:02 - Technological Breakthrough 12:17 - Current Liver Transplant Issues 18:00 - Kidney Transplant Diversification 19:49 - Commercialisation Process 22:19 - FDA Approval 23:21 - Potential Market Opportunity 24:41 - Further Applications for Product 26:10 - Oxford University Ecosystem 27:26 - Revenue Trajectory 28:59 - Long Term Outlook 30:28 - Competitive Landscape 32:54 - Corporate Values 35:23 - Regulatory Process 37:53 - Why it Matters to Patients 40:11 - Advice for Young People 43:08 - Investor Relations DISCLAIMER All content on the Money Maze Podcast is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions. Guests and presenters may have positions in any of the investments discussed. Please note, whilst the Money Maze Podcast is funded by third party sponsorships and is editorially independent, our Curated Podcast spin-off show is funded and made possible by the firms featured in the series.